Sorry, you need to enable JavaScript to visit this website.

dhcf

Department of Health Care Finance - DHCF
 

DC Agency Top Menu

-A +A
Bookmark and Share

Transmittal 22-25 - New Hepatitis C Policy


Wednesday, August 24, 2022

The purpose of this transmittal is to outline policy changes that the District Medicaid program will implement effective September 1, 2022, to expand access to Hepatitis C treatment by eliminating existing barriers to orally administered Direct Acting Antivirals (DAAs) used in the current treatment of chronic Hepatitis C infections for Fee-for-Service (FFS) and Managed Care Plan (MCP) enrolled beneficiaries.